Saturday, October 31, 2020 2:03:44 AM
http://www.ipharminc.com/press-release/2020/3/12/innovation-pharmaceuticals-announces-testing-procedures-of-brilacidin-against-coronavirus-covid-19
Todays preprint article gave an update on the plan to study Brilacidin against some viruses
"Experiments conducted in endemic human coronaviruses are ongoing, with additional testing planned in other lethal coronaviruses (MERS-CoV, SARS-CoV), toward assessing the potential of brilacidin as a broad spectrum inhibitor of coronaviruses. "
Today's PR also mentioned the study of Brilacidin used as an inhaler for Covid-19.
"Additional formulation work is planned for the inhaled delivery of brilacidin for prophylactic use, toward controlling infection in the nasal passage and lungs by leveraging brilacidin’s ability to inhibit SARS-CoV-2 by disrupting viral integrity and impacting viral entry. Such development efforts, if successful, may enable brilacidin to emerge as a particularly effective and differentiated antiviral by preventing and/or decreasing early infectivity due to SARS-CoV-2"
https://static1.squarespace.com/static/5715352e20c647639137f992/t/5f9b5de065b30770ea051cfd/1604017708904/Brilacidin+COVID-19+Manuscript+and+Supplemental+Information+fv+10.30.20.pdf
I have been told the FDA requires extensive testing of inhalers. It is good to hear we are going to start studying the inhaler in the RBL soon.
The other viruses you mentioned would all have to be studied separately.
MERS and SARS would require intensive IV treatment due to its much higher mortality rate.
Viruses with a protein/lipid/glycoprotein outer covering or capsid may be studied since Brlacidin's MOA is penetrating the outer viral coats.
The link below outlines viruses with a capsid and the list includes influenza, coronaviruses, adenoviruses {common cold}, herpes viruses, Flavivirus {encephalitis, Dengue,Zika},HPV,Hepatitis BC and D and others
https://www.amboss.com/us/knowledge/General_virology
IPIX and Dr DeGrado have stated Brilacidin may be an effective treatment against a number of viruses.
GLTA Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM